pirfenidone capsule

DRUG2 trials

Sponsors

University of Michigan, Beijing Continent Pharmaceutical Co, Ltd.

Conditions

Chronic Lung Allograft DysfunctionDisorder Related to Lung TransplantationRenal Insufficiency

Phase 1

Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics

Beijing Continent Pharmaceutical Co, Ltd.Renal Insufficiency

Start: 2019-08-27End: 2022-06-30Target: 24Updated: 2022-03-29

Phase 2

Studying the Treatment Effect of Pirfenidone in Chronic Lung Allograft Dysfunction (STOP-CLAD)

TerminatedNCT03473340

University of MichiganChronic Lung Allograft Dysfunction, Disorder Related to Lung Transplantation

Start: 2018-04-27End: 2021-08-20Updated: 2022-08-17